Search Results
133 Results for 'Drug Discovery & Development'
PAGE 6 OF 6
Technology
Method to Screen for Novel Antibiotics
The antibiotic vancomycin targets the peptidoglycan-containing bacterial cell wall. Inducible resistance to vancomycin and other glycopeptide antibiotics is becoming a serious health problem, necessit...
Learn More
Learn More
Bernard Weisblum, Robert Giannattasio, Arcady Grenader, Andrew Ulijasz, David Kovalic | P96061US
Technology
Tsp1 -/- Stz Mice, A Model For Diabetes
Effective and non-destructive treatments are needed for diabetic retinopathy, a major cause of blindness in the United States. Thrombospondin1 (TSP1), a matricellular protein that inhibits angiogenesi...
Learn More
Learn More
Nader Sheibani-Karkhaneh, Christine Sorenson | P06036US
Technology
Stem Cell Marker for Breast Cancer
In patients who develop breast cancer, malignant tumors frequently begin in somatic mammary stem cells. In addition, breast tumors have a stem cell component that propagates the tumor, which may expla...
Learn More
Learn More
Caroline Alexander, Bart Williams, Charlotta Lindvall, Nisha Badders | P07136US
Technology
Methods and Materials for Assaying Non-SCD1 Isoforms
Stearoyl-CoA desaturase (SCD) is the rate-limiting enzyme in the biosynthesis of monounsaturated fatty acids. Inhibitors of SCD may be useful therapeutics for diseases such as obesity and diabetes.
Learn More
Learn More
James Ntambi, Makoto Miyazaki | P05362US
Technology
Novel Candidates for an Improved Tuberculosis Vaccine
Approximately one-third of the world’s population is infected with the bacterium Mycobacterium tuberculosis, the causative agent of tuberculosis (TB). Five to 10 percent of non-immunocompr...
Learn More
Learn More
Adel Talaat, Bassam Abomoelak, Sarah Ward | P09203US02
Technology
Vaccine Candidates Against Johne's Disease
Johne’s disease is a contagious, chronic and usually fatal wasting disease that primarily affects the small intestine of ruminants. It is a worldwide problem with no known treatment and infects ...
Learn More
Learn More
Adel Talaat | P05446US
Technology
Type 1 Polyketide Synthase Extender Units
Microorganisms produce a variety of biologically active secondary metabolites, which display a range of useful antibiotic and immunosuppressant activities. One class of secondary metabolites, known as...
Learn More
Learn More
Michael Thomas, Jo Handelsman, Yolande Chan, Angela Podevels | P06464US
Technology
Novel Antibacterial Small Molecules
As the incidence of antibiotic resistance among bacteria continues to rise, the discovery of new antibacterial compounds has become increasingly critical to fighting infectious disease. According to t...
Learn More
Learn More
Helen Blackwell, Matthew Bowman, Joseph Stringer | P07517US